These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7951640)

  • 1. Divalproex sodium in the treatment of aggressive behavior.
    Wilcox J
    Ann Clin Psychiatry; 1994 Mar; 6(1):17-20. PubMed ID: 7951640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divalproex sodium as a treatment for borderline personality disorder.
    Wilcox JA
    Ann Clin Psychiatry; 1995 Mar; 7(1):33-7. PubMed ID: 8541935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.
    Frankenburg FR; Zanarini MC
    J Clin Psychiatry; 2002 May; 63(5):442-6. PubMed ID: 12019669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.
    Hollander E; Swann AC; Coccaro EF; Jiang P; Smith TB
    Am J Psychiatry; 2005 Mar; 162(3):621-4. PubMed ID: 15741486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divalproex sodium in the treatment of aggressive behavior and dysphoria in patients with organic brain syndromes.
    Horne M; Lindley SE
    J Clin Psychiatry; 1995 Sep; 56(9):430-1. PubMed ID: 7665542
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
    Buckley PF; Paulsson B; Brecher M
    J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
    Gobbi G; Gaudreau PO; Leblanc N
    J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of divalproex sodium in elderly psychiatric patients with mixed diagnoses.
    Puryear LJ; Kunik ME; Workman R
    J Geriatr Psychiatry Neurol; 1995 Oct; 8(4):234-7. PubMed ID: 8561838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of agitation in bipolar disorder across the life cycle.
    Alderfer BS; Allen MH
    J Clin Psychiatry; 2003; 64 Suppl 4():3-9. PubMed ID: 12672259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.
    Hollander E; Allen A; Lopez RP; Bienstock CA; Grossman R; Siever LJ; Merkatz L; Stein DJ
    J Clin Psychiatry; 2001 Mar; 62(3):199-203. PubMed ID: 11305707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divalproex sodium for impulsive aggressive behavior in patients with personality disorder.
    Kavoussi RJ; Coccaro EF
    J Clin Psychiatry; 1998 Dec; 59(12):676-80. PubMed ID: 9921702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label trial of divalproex extended-release in the treatment of borderline personality disorder.
    Simeon D; Baker B; Chaplin W; Braun A; Hollander E
    CNS Spectr; 2007 Jun; 12(6):439-43. PubMed ID: 17545954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of anticonvulsants in treating agitated demented elderly patients.
    Grossman F
    Pharmacotherapy; 1998; 18(3):600-6. PubMed ID: 9620110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of divalproex sodium in the treatment of agitation associated with major depression.
    Debattista C; Solomon A; Arnow B; Kendrick E; Tilston J; Schatzberg AF
    J Clin Psychopharmacol; 2005 Oct; 25(5):476-9. PubMed ID: 16160625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid for agitation in dementia.
    Lonergan ET; Cameron M; Luxenberg J
    Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
    Barzman DH; DelBello MP; Adler CM; Stanford KE; Strakowski SM
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):665-70. PubMed ID: 17201610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of borderline personality disorder with mood instability with divalproex sodium: series of ten cases.
    Townsend MH; Cambre KM; Barbee JG
    J Clin Psychopharmacol; 2001 Apr; 21(2):249-51. PubMed ID: 11270932
    [No Abstract]   [Full Text] [Related]  

  • 19. The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: a pharmacoepidemiology study.
    Zarate CA; Tohen M; Narendran R; Tomassini EC; McDonald J; Sederer M; Madrid AR
    J Clin Psychiatry; 1999 Apr; 60(4):232-6. PubMed ID: 10221283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injectable atypical antipsychotics for agitation in borderline personality disorder.
    Pascual JC; Madre M; Soler J; Barrachina J; Campins MJ; Alvarez E; Pérez V
    Pharmacopsychiatry; 2006 May; 39(3):117-8. PubMed ID: 16721704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.